EnsoSleep allows our sleep technologists to spend more time on patient care and education, without sacrificing quality in the preparation of test results. EnsoSleep has improved patient engagement and is helping improve long-term adherence to treatment.
FDA Cleared Total Sleep Time (TST) for Home Sleep Apnea Testing (HSAT) Devices
EnsoSleep Artificial Intelligence (AI) scoring technology streamlines the delivery and improves the reliability of HSAT results by providing TST via EnsoTST.
EnsoTST enables the measurement of TST through commonly available data found in HSATs and helps clinicians accurately identify AHI severity levels.
Have Confidence in HSAT Results
EnsoTST uses PPG and respiratory channels to calculate the TST in home tests and helps improve confidence in home sleep testing results and diagnosis for clinicians and patients. TST demonstrated 90% overall agreement compared to ⅔ majority manually scored EEG-based staging and total sleep time.
Navigate the Changing Reimbursement Landscape
Adding EnsoTST to home testing devices that don’t natively track sleep time provides a pathway to increased reimbursement for HSATs, (using CPT code 95800 vs. 95806). For more information regarding billing and coding for HSATs, reference EnsoData’s HSAT and Total Sleep Time Billing and Coding Guide or check with your payer.
Adding EnsoSleep’s AI has changed everything in terms of how fast and how accurate we are testing more than anything. After all, speed means nothing if it’s not accurate. With EnsoSleep, we can offer better service and faster service for patients. Results are ready from one day to the next, it’s no longer two or…
[EnsoSleep] works out well for us. If your lab is a busy lab like ours it is very much worth it. It frees up a lot of time which allows me to concentrate on other things.
Thanks so much [for EnsoSleep], I don’t know what I would do without it!
EnsoSleep has very accurate scoring. I feel like it has improved every phase of the implementation. EnsoSleep is consistent, and there are few outliers.
EnsoSleep has decreased our costs, decreased our processing time, improved sleep physician buy-in regarding the accuracy of sleep reports, and increased the scalability of our business model.
We’re probably the best testimonial you will find, because we were highly efficient prior to meeting the EnsoData team. We’ve scratched our heads in the past about whether an AI could in fact turn into an economic winner for us, and as we’ve gone down that path with EnsoSleep, it’s been a successful run so…
We’re very satisfied with the results we’ve seen with EnsoData and we feel we’re going to be more efficient and more cost-effective as a result. At the end of the day, we’re talking about how artificial intelligence provides a service that can have a tremendous impact on our ability to grow as an organization.
I think that automated scoring, using artificial intelligence, really is the future. Compared to human scoring, it is much more reliable, reproducible, and scalable. As things get more and more accurate, I really believe that AI scoring is where sleep medicine goes. And by accurate, I mean the scoring results are reproducible at scale and…
EnsoSleep AI scoring frees up time for us to enhance patient care, develop new programs, build relationships with our referring network of physicians, and improve quality reporting initiatives.
Improve Quality of Patient Care in the HSAT Environment
We’re excited to provide revolutionary AI capability for reliable HSAT and sleep measurement at home.
Simply fill out our form and a team member will reach out to schedule an online demo at your convenience. During the meeting, we’ll discuss the unique needs of your clinic and demonstrate how EnsoSleep with EnsoTST fits into your current workflow.
Discover how EnsoSleep with EnsoTST provides clinicians with more opportunities to focus on patients, and improve the overall quality of care, diagnosis, and treatment for the HSAT environment.
Read our EnsoSleep Performance Reference Document, which includes the results of our clinical validation studies.
EnsoSleep Receives Expanded FDA Clearance for Pediatrics, EnsoViewer, Total Sleep Time (EnsoTST)
In July 2021, the FDA issued a 510(k) clearance for the artificial intelligence software platform EnsoSleep, expanding the AI’s reach to pediatric populations ages 13 and above, and for two additional products to support sleep centers in achieving their goal of providing excellent patient care, EnsoViewer and Total Sleep Time.
EnsoSleep is an FDA cleared AI-assisted sleep scoring and analysis solution that automates the scoring of studies, and reduces the time RPSGTs spend scoring. Consistent, reliable results provide clinicians with more time to expand patient care, improve outcomes and treat more patients.
EnsoViewer is a sleep study reviewing, editing, and reporting tool cleared by the FDA in 2021. Sleep professionals can use EnsoViewer to access all their studies for all their devices, across all locations, in one easy-to-use, interoperable, cloud-based platform.